Albumedix Ltd

Organisation type
Mr Dave Mead
Business Development Director 

Celentyx Ltd

Organisation type
Dr Omar Qureshi
VP,Scientific Operations 
Dr Nicholas Barnes


Medherant is a leading developer of next-generation transdermal drug delivery patches.

Transdermal delivery of drugs from a patch provides better control of the dose than achieved with gels, ointments and creams.  However, the currently available technologies limit the types of drugs that can be used and the quantities that can be loaded into the patch.  Medherant’s TEPI Patch® is formulated with a novel polymer adhesive that is mixed with the drug.

One of the key advantages of the TEPI Patch® technology is that a greater quantity of drug can be blended with the adhesive.  This enables lower potency drugs to be formulated as a patch and provides the opportunity to increase the dose of drugs already administered via a patch.  The TEPI Patch® also provides a better experience for the user as it does not leave a residue around the patch – referred to as ‘cold flow’ – and has excellent adhesion whilst still being easy and painless to remove.

Medherant is developing its own TEPI Patch® products and working with third parties to assess the suitability of the technology for their drugs.  

The Company expects to earn revenues from licensing both its products and its technology for use with specific drugs.

Organisation type
Mr Nigel Davis

Mereo BioPharma Group plc

Organisation type
Dr Donald Coppen
Director, Corporate Development 

Novintum Bioscience

Organisation type
Dr Tim Sparey

Pneumagen Ltd

Research and experimental development on biotechnology.

Organisation type
Mr Douglas Thomson

Redx Pharma Ltd

Organisation type
Mr Mark Craighead
Director of Business Development 
Mr Nicholas Adams
Chief Business Officer 
Mr Richard Armer
Chief Scientific Officer 

The Institute of Cancer Research

Organisation type
Dr Angela Kukula
Director of Enterprise 
Mrs Jennifer Hodgson
Business Development Manager 
Mr Henry French
Int Head of Content & Partnerships - Commiunications 

Therakind Ltd

Organisation type
speciality pharma, paediatrics
Ms Susan Conroy


Organisation type
Ms Laura Lane